-
SCIENCE & INNOVATIONTargeting Neuroinflammation in Multiple Sclerosis2021-10-13LL -
SCIENCE & INNOVATIONResponsive Innovation in Metastatic Breast Cancer Research2021-10-13LL -
-
SCIENCE & INNOVATIONA Timeline of Innovation in Hemophilia Treatment2021-07-16LL -
SCIENCE & INNOVATIONSanofi's multi-front attack on cancer2021-05-20LL -
SCIENCE & INNOVATIONClinical Trials Can Make Anyone a Hero2021-05-20LL -
SCIENCE & INNOVATIONThe Value of Industry-Academic Collaboration2021-05-06LL -
SCIENCE & INNOVATIONThe Next Breath: Advancing Knowledge to Transform Asthma Care2021-05-05LL -
SCIENCE & INNOVATIONAccelerating Genomic Medicine at Sanofi2021-03-15LL -
-
SCIENCE & INNOVATIONHow Registries Accelerate Rare Disease Research2021-03-12LL -
-
SCIENCE & INNOVATIONTaking Down Type 2 Inflammatory Disease2020-11-30LL -
-
-
SCIENCE & INNOVATIONMetabolic Hub May Offer New Hope for Rare Diseases2020-10-20LL -
SCIENCE & INNOVATIONThe Science Behind Sanofi's Hemophilia Pipeline2020-09-10LL -
YOUR HEALTHVaccines: our best line of defense against infectious diseases like COVID-192020-07-27LL -
-
ABOUT USIdentifying a New Target to Address an old challenge: CEACAM5 and Lung Cancer2020-06-15LL -
ABOUT USSupporting Scientific Progress Through Clinical Trials2020-05-20LL -
SCIENCE & INNOVATIONSanofi Researchers Turn a Hunch into a Clinical Study for Rare Diseases2020-02-24LL -
-
-
Manufacturing vaccines is a complex journey
-
SCIENCE & INNOVATIONTargeting Estrogen Receptors in Metastatic Breast Cancer -
